← positive_eps_streak (all companies) · NEOG (all signals) · all methodology

positive_eps_streak on NEOGEN CORP (NEOG)

SIC 2835 — In Vitro & In Vivo Diagnostic Substances · CIK 711377 · default direction: long

Definition

Fires on companies with consecutive years of positive earnings — quality compounder candidates. Surfaces stable franchises with earnings durability, not speculative growth.

Every time the signal fired on NEOG

FYFiling dateEvent date1d5d20d60d252d
FY20222022-07-272022-07-27-2.06%-4.60%-11.96%-53.59%-0.69%
FY20212021-07-302021-07-30-0.87%+0.48%+0.44%-4.36%-48.16%
FY20202020-07-302020-07-30+1.88%+6.69%+0.64%-4.06%+15.62%
FY20192019-07-302019-07-30+1.03%-0.25%-1.71%-7.09%+7.03%
FY20182018-07-272018-07-27-1.23%+0.60%+9.58%-22.24%-12.77%
FY20172017-07-282017-07-28+1.26%+2.69%+2.49%+23.60%+63.98%
FY20162016-07-292016-07-29+1.43%+0.05%+6.64%-4.84%+19.44%
FY20152015-07-302015-07-30+2.23%+1.07%-8.43%-11.12%-3.11%
FY20142014-07-302014-07-30-2.59%-2.63%-6.43%-4.95%+27.00%
FY20132013-07-302013-07-30-0.18%+2.17%-4.68%+23.75%+18.82%

Forward returns are stock returns from event date (next trading day after filing). Sign is raw stock direction; the trade direction is in the calibration table below.

Universe-wide calibration (this signal across all companies)

Horizonn eventsGross stock retHit rateTrade dirNet PnLCost (bps)r/σ net
1d21,256+0.05%+49.53%long-0.16%22-0.04
5d21,258+0.10%+50.10%long-0.10%22-0.00
20d21,218-0.80%+49.80%long-1.03%22-0.04
60d19,852+1.64%+54.15%long+1.48%22+0.04
252d19,501+13.65%+64.44%long+13.47%22+0.27

Net PnL is direction × stock return − round-trip execution cost (5 bps half-spread + ADV-tiered borrow). See positive_eps_streak methodology for the full audit.


Data: /api/company/711377/financials